Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net loss	$ (8,406)	$ (5,887)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,497	1,409
Other debt related costs included in interest expense	820	1,362
Termination fees included in payoff of 2013 Loan and Security Agreement	0	277
Provision for bad debt expense	30	117
Share-based compensation expense	162	470
Mark to market of SWK Warrant 2 (defined below)	0	59
Issuance of common stock in connection with the Merger	364	0
Issuance of common stock in connection with First Amendment to Credit Agreement	0	50
Write-off of SWK Warrant 2	0	(887)
Change in assets and liabilities:
Accounts receivable	125	72
Inventories	6	(414)
Other assets	149	(52)
Accounts payable, accrued expenses and other liabilities	(1,835)	(1,365)
Net cash used in operating activities	(6,575)	(4,848)
Cash flows from investing activities:
Capital expenditures	(236)	(191)
Cash acquired from Merger with Provant Health Solutions	1,936	0
Net cash used in investing activities	1,700	(191)
Cash flows from financing activities:
Payments under credit facility	(18,098)	(17,044)
Principal payments on Term Loan	0	(954)
Proceeds from amendment of Term Loan	2,824	0
Issuance of common stock and warrants, net of issuance costs	3,414	4,574
Payments on capital lease obligations	(53)	0
Debt issuance costs	0	(36)
Net cash provided by financing activities	4,259	3,106
Net decrease in cash and cash equivalents	(616)	(1,933)
Cash and cash equivalents at beginning of period	1,866	2,035
Cash and cash equivalents at end of period	1,250	102
Supplemental disclosure of non-cash investing and financing activities:
Fixed assets vouchered but not paid	198	28
Fair value of common stock issued as Merger consideration	6,792	0
Fair value of debt assumed in the Merger	7,110	0
Issuance of common stock in connection with Second Amendment to Credit Agreement	0	100
Payoff of 2013 Loan and Security Agreement by SCM	0	(2,552)
Opening outstanding borrowings under 2016 Credit and Security Agreement	0	3,028
Debt issuance costs incurred for 2016 Credit and Security Agreement	0	236
Supplemental disclosure of cash paid during period for:
Income taxes	25	31
Interest	488	466
Provant
Cash flows from financing activities:
Payments under credit facility	(4,684)	0
2016 Credit and Security Agreement
Cash flows from financing activities:
Borrowings under credit facility	18,856	16,566
Seasonal Facility
Cash flows from financing activities:
Borrowings under credit facility	2,000	0
SWK
Adjustments to reconcile net loss to net cash used in operating activities:
Mark to market of SWK Warrant 2 (defined below)	361	0
Century
Adjustments to reconcile net loss to net cash used in operating activities:
Mark to market of SWK Warrant 2 (defined below)	$ 152	$ 0